InvestmentUpdated on 27 November 2024

dAIgnostics - AI supported neuroinflammatory disease early diagnostics

Domagoj Frank

CEO at dAIgnostics

Bobovje (City of Krapina), Croatia

About

dAIgnostics' methodology for the early diagnosis of Amyotrophic Lateral Sclerosis, Parkinson’s disease, Alzheimer’s disease, and neuroinflammatory diseases is founded on 30 years of extensive research and experimentation, backed by €3.5M in research grants to date. Leveraging advanced AI algorithms, our solution facilitates population-wide screening for early disease detection in general healthcare settings and empowers pharmaceutical companies to develop early-stage treatments. This groundbreaking approach has the potential to improve the lives of millions globally while creating a significant new segment within the global pharmaceutical market.

We have assembled a regional multidisciplinary super-team of renowned scientists, seasoned business experts, and visionary angel investors. Join us on our journey to develop a Minimum Viable Product, setting the stage for a company poised to be valued at hundreds of millions of Euros!

Stage

  • Seed and Development

Applies to

  • Biotech, Pharma and Cosmetics

Similar opportunities